Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Hangzhou Alltest Biotech Co. Ltd. A
688606Current price
69.33 CNY
+0.48 CNY (+0.70%)
Last closed
68.9 CNY
Company
www.alltests.com.cn
ISIN
CNE1000053G6
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
Shanghai Stock Exchange
Capitalization
5 698 616 543 CNY
Yield for 12 month
-10.46 %
1Y
3Y
5Y
10Y
15Y
688606
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China. Address: Building 3, 4, 5, Hangzhou, China, 310018
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
20.3926Dividend Yield
4.34 %Current Year
+762 213 240 CNY
Last Year
+3 422 316 345 CNY
Current Quarter
+198 540 318 CNY
Last Quarter
+201 911 997 CNY
Current Year
+371 822 716 CNY
Last Year
+2 051 088 021 CNY
Current Quarter
+119 064 790 CNY
Last Quarter
+101 216 692 CNY
Key Figures 688606
1 year
3 years
5 years
10 years
EBITDA
252 608 206 CNY
Operating Margin TTM
PE Ratio
20.3926
Return On Assets TTM
3.51 %
PEG Ratio
–
Return On Equity TTM
7.25 %
Wall Street Target Price
–
Revenue TTM
820 878 607 CNY
Book Value
49.5 CNY
Revenue Per Share TTM
Dividend Share
1.51 CNY
Quarterly Revenue Growth YOY
28.7 %
Dividend Yield
4.34 %
Gross Profit TTM
3 486 075 045 CNY
Earnings per share
3.52 CNY
Diluted Eps TTM
3.52 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
144.5 %
Profit Margin
34.02 %
Dividend Analytics 688606
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
157 %Dividend History 688606
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
3
Ex Dividend Date
25.10.2024
Forward Annual Dividend Yield
4.22 %
Last Split Factor
1.48:1
Payout Ratio
42.98 %
Last Split Date
09.06.2023
Dividend Date
–
Stock Valuation 688606
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
20.3926
Forward PE
–
Enterprise Value Revenue
3.676
Price Sales TTM
7.026
Enterprise Value EBITDA
9.7497
Price Book MRQ
1.4544
Financials 688606
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 688606
For 52 weeks
45.12 CNY
79.05 CNY
50 Day MA
60.47 CNY
Shares Short Prior Month
–
200 Day MA
59.11 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart